Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration

Jiao Jiao,Shujie He,Yiqiu Wang,Yuzhi Lu,Muyang Gu,Dan Li,Tingting Tang,Shaofang Nie,Min Zhang,Bingjie Lv,Jingyong Li,Ni Xia,Xiang Cheng
DOI: https://doi.org/10.1007/s00395-021-00886-4
IF: 12.416
2021-07-24
Basic Research in Cardiology
Abstract:Abstract Overactivated inflammatory responses contribute to adverse ventricular remodeling after myocardial infarction (MI). Regulatory B cells (Bregs) are a newly discovered subset of B cells with immunomodulatory roles in many immune and inflammation-related diseases. Our study aims to determine whether the expansion of Bregs exerts a beneficial effect on ventricular remodeling and explore the mechanisms involved. Here, we showed that adoptive transfer of Bregs ameliorated ventricular remodeling in a murine MI model, as demonstrated by improved cardiac function, decreased scar size and attenuated interstitial fibrosis without changing the survival rate. Reduced Ly6C hi monocyte infiltration was found in the hearts of the Breg-transferred mice, while the infiltration of Ly6C lo monocytes was not affected. In addition, the replenishment of Bregs had no effect on the myocardial accumulation of T cells or neutrophils. Mechanistically, Bregs reduced the expression of C–C motif chemokine receptor 2 (CCR2) in monocytes, which inhibited proinflammatory monocyte recruitment to the heart from the peripheral blood and mobilization from the bone marrow. Breg-mediated protection against MI was abrogated by treatment with an interleukin 10 (IL-10) antibody. Finally, IL-10 neutralization reversed the effect of Bregs on monocyte migration and CCR2 expression. The present study suggests a therapeutic value of Bregs in limiting ventricular remodeling after MI through decreasing CCR2-mediated monocyte recruitment and mobilization.
cardiac & cardiovascular systems
What problem does this paper attempt to address?
The paper aims to explore the impact of regulatory B cells (Bregs) on ventricular remodeling after myocardial infarction (MI) and its potential mechanisms. The study found that Bregs can improve ventricular remodeling after myocardial infarction by reducing the inflammatory response of monocyte migration to the heart. Specifically, Bregs inhibit the entry of pro-inflammatory monocytes into the infarcted myocardium by reducing the expression of C–C chemokine receptor type 2 (CCR2) on monocytes, thereby alleviating ventricular remodeling. Additionally, the study confirmed that interleukin-10 (IL-10) plays a key role in the cardioprotective effects mediated by Bregs. These findings suggest that Bregs may have the potential to improve clinical outcomes after myocardial infarction.